NASDAQ:ALDR Alder Biopharmaceuticals (ALDR) Stock Price, News & Analysis → The only AI company to buy (From Porter & Company) (Ad) Free ALDR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$18.88▼$18.8850-Day Range$18.88▼$18.8852-Week Range$8.39▼$19.12VolumeN/AAverage Volume5.12 million shsMarket Capitalization$1.58 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Alder Biopharmaceuticals alerts: Email Address Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About Alder Biopharmaceuticals Stock (NASDAQ:ALDR)Alder BioPharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It discovers, develops, and commercializes therapeutic antibodies to transform the treatment paradigm for patients with migraine in the United States, Australia, and Ireland. The company's lead product candidate is eptinezumab, a monoclonal antibody (mAb) inhibiting calcitonin gene-related peptide, which is in the late-stage clinical development for the prevention of migraine. It also develops ALD1910, a preclinical mAb that inhibits pituitary adenylate cyclase-activating polypeptide-38 for migraine prevention; and Clazakizumab, a mAb inhibiting the pro-inflammatory cytokine interleukin-6 that has completed two Phase 2b clinical trials. The company has strategic collaboration with CSL Limited for the development of clazakizumab as a therapeutic option for solid organ transplant rejection. Alder BioPharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Bothell, Washington.Read More Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ALDR Stock News HeadlinesMay 28, 2024 | msn.comCommunity stalwart Angela Alder granted Freedom of the Town of SawbridgeworthMay 24, 2024 | msn.comOHSAA track & field: Jonathan Alder, Licking Valley boys win Division II regional titlesMay 23, 2024 | msn.comGreg Kennedy's perfect game for Jonathan Alder highlights OHSAA baseball district finalsMay 21, 2024 | msn.comYoung girl's cancer battle inspires Phil to shave bushy beard off for Alder HeyMay 17, 2024 | msn.comTop-ranked Jonathan Alder ends Licking Valley's championship baseball seasonMay 9, 2024 | msn.comAlder Hey delays community park return plan againMay 8, 2024 | benzinga.comJames J Bochnowski's Net WorthMay 6, 2024 | msn.comDad turned away from Alder Hey car park as he had electric vehicleApril 24, 2024 | msn.comAlder Hey unveils plans to take on former police stationApril 23, 2024 | msn.comControversial housing plans on old Alder Hey site get green lightApril 18, 2024 | msn.comRomesh Ranganathan makes wonderful gesture during surprise Alder Hey visitApril 16, 2024 | msn.comRomesh Ranganathan in surprise visit to Alder HeyApril 15, 2024 | msn.comRomesh Ranganathan's incredible gesture after Alder Hey visitApril 12, 2024 | msn.comFormer Alder Hey doctor who emptied mum's bin on driveway is bannedApril 12, 2024 | msn.comGrand National winners greet children at Alder Hey as 35th runner namedApril 11, 2024 | msn.comMore than four in five A&E arrivals at Alder Hey Children's Hospital seen within four hours – meeting Government's recovery targetApril 11, 2024 | msn.comFormer Alder Hey doctor turned up at mum's home and emptied bin onto drivewayApril 2, 2024 | msn.comTraffic lights out after car crash in Alder Road, PooleMarch 21, 2024 | msn.comObama Drive? Alder proposes renaming prominent Chicago street for former presidentMarch 18, 2024 | msn.comTributes paid to lifelong Swindon Town supporter Ann AlderMarch 14, 2024 | msn.comRishi Sunak's NHS pledge one year on: Waiting lists up at Alder Hey Children's HospitalMarch 12, 2024 | msn.comMore women than men working as doctors at Alder Hey Children's Hospital – bucking trend across NHSMarch 9, 2024 | msn.comHartley, Jonathan Alder win OHSAA Division II boys basketball district championshipsFebruary 19, 2024 | msn.comSchoolboy flown to Alder Hey in serious condition after mountain fallFebruary 9, 2024 | msn.comAlder Hey Children's Trust cares for eight patients with Covid-19 in hospitalSee More Headlines Receive ALDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alder Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/07/2018Today6/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:ALDR CUSIPN/A CIK1423824 Webwww.alderbio.com Phone425-205-2900FaxN/AEmployees202Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($4.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-296,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-226.13% Return on Assets-66.86% Debt Debt-to-Equity Ratio1.74 Current Ratio8.94 Quick Ratio8.94 Sales & Book Value Annual Sales$1.62 million Price / Sales977.10 Cash FlowN/A Price / Cash FlowN/A Book Value$1.61 per share Price / Book11.73Miscellaneous Outstanding Shares83,840,000Free FloatN/AMarket Cap$1.58 billion OptionableOptionable Beta2.64 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesDr. John A. Latham (Age 59)Co-Founder & Chief Scientific Officer Mr. Larry K. Benedict (Age 58)Principal Accounting Officer & Exec. VP Dr. Jeffrey T. L. Smith (Age 59)Managing Director of Alder Biopharmaceuticals Limited Mr. Robert W. Azelby (Age 51)Pres, CEO & Director Mr. Carlos CampoyChief Financial OfficerKey CompetitorsViking TherapeuticsNASDAQ:VKTXIonis PharmaceuticalsNASDAQ:IONSOrganon & Co.NYSE:OGNMadrigal PharmaceuticalsNASDAQ:MDGLSummit TherapeuticsNASDAQ:SMMTView All Competitors ALDR Stock Analysis - Frequently Asked Questions How were Alder Biopharmaceuticals' earnings last quarter? Alder Biopharmaceuticals Inc (NASDAQ:ALDR) issued its quarterly earnings results on Tuesday, August, 7th. The biopharmaceutical company reported ($1.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.05) by $0.01. What other stocks do shareholders of Alder Biopharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Alder Biopharmaceuticals investors own include NVIDIA (NVDA), AbbVie (ABBV), (CPXX) (CPXX), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), Synergy Pharmaceuticals (SGYP), Sarepta Therapeutics (SRPT) and Celldex Therapeutics (CLDX). This page (NASDAQ:ALDR) was last updated on 6/5/2024 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club| SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises| SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals| Sponsored[Webinar] Understanding Covered CallsDiscover the details of this option-selling strategy.OIC| SponsoredWhat’s Pelosi Buying Now?They Make the Top Investors Look Like Amateurs They beat the market for three years straight… avoided some ...Altimetry| SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media| SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press| SponsoredClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an eff...Crypto Swap Profits| Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alder Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alder Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.